介入诊疗程序中患者皮肤最大受照剂量的检测与评价

目的测定冠脉造影、肝动脉造影、射频消融、脑动脉造影等介入程序中对患者主射束皮肤剂量分布和最大皮肤受照剂量，了解患者皮肤能否发生确定性效应。方法在冠脉造影、肝动脉造影和射频消融3种手术曝光前每个患者背部放9个测量点，每个点2片LiF（Mg，Cu，P）剂量片；脑动脉造影曝光前患者正、侧位各放1个测量点。手术后进行TLD测量。结果肝动脉造影手术时，患者皮肤最大吸收剂量为1683．9mGy，平均吸收剂量607．3mGy；脑动脉造影正位时最大值可达959．3mGy，平均值418．8mGy；侧位最高达704mGy。平均191．52mGy；射频消融最高值为853．8mGy。平均219．7mGy；冠脉造影最大值为456．1mGy，平均227．6mGy。结论本实验结果是对皮肤最大剂量的一种估计值，尚不能精确提供患者皮肤受照的最大值。因为剂量片布放不够密集，可能没有包括很小的高剂量部位。     

Main clinical, therapeutic and technical factors related to patient's maximum skin dose in interventional cardiology procedures

Objective: The study aimed to characterise the factors related to the X-ray dose delivered to the patient's skin during interventional cardiology procedures. Methods: We studied 177 coronary angiographies (CAs) and/or percutaneous transluminal coronary angioplasties (PTCAs) carried out in a French clinic on the same radiography table. The clinical and therapeutic characteristics, and the technical parameters of the procedures, were collected. The dose area product (DAP) and the maximum skin dose (MSD) were measured by an ionisation chamber (Diamentor; Philips, Amsterdam, The Netherlands) and radiosensitive film (Gafchromic; International Specialty Products Advanced Materials Group, Wayne, NJ). Multivariate analyses were used to assess the effects of the factors of interest on dose. Results: The mean MSD and DAP were respectively 389 mGy and 65 Gy cm(-2) for CAs, and 916 mGy and 69 Gy cm(-2) for PTCAs. For 8% of the procedures, the MSD exceeded 2 Gy. Although a linear relationship between the MSD and the DAP was observed for CAs (r=0.93), a simple extrapolation of such a model to PTCAs would lead to an inadequate assessment of the risk, especially for the highest dose values. For PTCAs, the body mass index, the therapeutic complexity, the fluoroscopy time and the number of cine frames were independent explanatory factors of the MSD, whoever the practitioner was. Moreover, the effect of technical factors such as collimation, cinematography settings and X-ray tube orientations on the DAP was shown. Conclusion: Optimising the technical options for interventional procedures and training staff on radiation protection might notably reduce the dose and ultimately avoid patient skin lesions.     

A mathematical model for patient skin dose assessment in cardiac catheterization procedures

A mathematical model has been developed for the assessment of patient skin doses from cardiac catheterization procedures. This uses exposure and projection data stored in the DICOM image files. Since these contain only information about the acquisition runs, a correction is needed to estimate and include the contribution from fluoroscopy. Maximum skin doses calculated by the model were found to correlate well with those measured on Kodak EDR2 film. Three methods for including the contribution from fluoroscopy were investigated, and all successfully identified patients receiving skin doses in excess of 1 Gy. It is hoped to automate this tool for routine assessment of skin doses in our cardiac catheterization laboratories.     

Relationship between fluoroscopic time, dose-area product, body weight, and maximum radiation skin dose in cardiac interventional procedures

OBJECTIVE: Real-time maximum dose monitoring of the skin is unavailable on many of the X-ray machines that are used for cardiac intervention procedures. Therefore, some reports have recommended that physicians record the fluoroscopic time for patients undergoing fluoroscopically guided intervention procedures. However, the relationship between the fluoroscopic time and the maximum radiation skin dose is not clear. This article describes the correlation between the maximum radiation skin dose and fluoroscopic time for patients undergoing cardiac intervention procedures. In addition, we examined whether the correlations between maximum radiation skin dose and body weight, fluoroscopic time, and dose-area product (DAP) were useful for estimating the maximum skin dose during cardiac intervention procedures. MATERIALS AND METHODS: Two hundred consecutive cardiac intervention procedures were studied: 172 percutaneous coronary interventions and 28 cardiac radiofrequency catheter ablation (RFCA) procedures. The patient skin dose and DAP were measured using Caregraph with skin-dose-mapping software. RESULTS: For the RFCA procedures, we found a good correlation between the maximum radiation skin dose and fluoroscopic time (r = 0.801, p < 0.0001), whereas we found a poor correlation between the maximum radiation skin dose and fluoroscopic time for the percutaneous coronary intervention procedures (r = 0.628, p < 0.0001). There was a strong correlation between the maximum radiation skin dose and DAP in RFCA procedures (r = 0.942, p < 0.0001). There was also a significant correlation between the maximum radiation skin dose and DAP (r = 0.724, p < 0.0001) and weight-fluoroscopic time product (WFP) (r = 0.709, p < 0.0001) in percutaneous coronary intervention procedures. CONCLUSION: The correlation between the maximum radiation skin dose with DAP is more striking than that with fluoroscopic time in both RFCA and percutaneous coronary intervention procedures. We recommend that physicians record the DAP when it can be monitored and that physicians record the fluoroscopic time when DAP cannot be monitored for estimating the maximum patient skin dose in RFCA procedures. For estimating the maximum patient skin dose in percutaneous coronary intervention procedures, we also recommend that physicians record DAP when it can be monitored and that physicians record WFP when DAP cannot be monitored.     

Method of calculating patient skin surface dose in transcatheter arterial embolization

The usefulness of interventional radiology (IVR) in clinical practice is well known. However, patient dose in IVR has recently been increased as a result of the prolongation of fluoroscopic time and the increased number of radiographies. We studied a simple method of calculating skin surface dose in patients who underwent transcatheter arterial embolization (TAE) for the treatment of hepatocellular carcinoma by obtaining the value of a dose area product meter attached to the digital subtraction angiography system. In 20 subjects (15 men and 5 women, aged an average of 68.2+/-7.3 years, respectively) who underwent TAE, exposure conditions (tube voltage, tube current, time, and size of image intensifier) in a time series and last value indicated on the dose area product meter were recorded. A dosimetric phantom was placed at a position the same as that of the patient for TAE, the surface dose (SD) of the phantom was measured under various exposure conditions, and SD per unit mAs (SD/mAs) was obtained. Then the skin surface dose in each subject was estimated from the values of the exposure condition and SD/mAs. A high correlation was observed between the last value (x) on the dose area product meter and the estimated skin surface dose (y) (r=0.933), and the following regression equation was derived: y=0.005x-0.589. The skin surface dose calculated using the regression equation was compared with that obtained by the method recommended by the Japan Association on Radiological Protection in Medicine (JARPM), considering the value estimated from the value of exposure conditions with SD/mAs as the gold standard. The results indicated that the error in the method using the regression equation was significantly lower than that of the JARPM method (18.3+/-14.0% and 75.5+/-66.0%, respectively, p<0.01). In conclusion, the skin surface dose in TAE could be monitored with high precision using the value of the dose area product meter by obtaining the regression formula between the value of the dose area product meter and the skin surface dose estimated with the phantom values.     

Management of patient skin dose in fluoroscopically guided interventional procedures

PURPOSE: To simulate dose to the skin of a large patient for various operational fluoroscopic conditions and to delineate how to adjust operational conditions to maintain skin dose at acceptable levels. MATERIALS AND METHODS: Patient entrance skin dose was estimated from measurement of entrance air kerma (dose to air) to a 280-mm water phantom for two angiographic fluoroscopes. Effects on dose for changes in machine floor kVp, source-to-skin distance, air gap, electronic magnification, fluoroscopic dose rate control settings, and fluorographic dose control settings were examined. RESULTS: Incremental changes in operational parameters are multiplicative and markedly affect total dose delivered to a patient's skin. For long procedures, differences in doses of 8 Gy or more are possible for some combinations of operational techniques. CONCLUSIONS: Effects on skin dose from changes in operational parameters are multiplicative, not additive. Doses in excess of known thresholds for injury can be exceeded under some operating conditions. Adjusting operational parameters appropriately will markedly reduce dose to a patient's skin. Above all other operational factors, variable pulsed fluoroscopy has the greatest potential for maintaining radiation exposure at low levels.     

Radiation doses in interventional radiology procedures: the RAD-IR study: part II: skin dose

PURPOSE: To determine peak skin dose (PSD), a measure of the likelihood of radiation-induced skin effects, for a variety of common interventional radiology and interventional neuroradiology procedures, and to identify procedures associated with a PSD greater than 2 Gy. MATERIALS AND METHODS: An observational study was conducted at seven academic medical centers in the United States. Sites prospectively contributed demographic and radiation dose data for subjects undergoing 21 specific procedures in a fluoroscopic suite equipped with built-in dosimetry capability. Comprehensive physics evaluations and periodic consistency checks were performed on each unit to verify the stability and consistency of the dosimeter. Seven of 12 fluoroscopic suites in the study were equipped with skin dose mapping software. RESULTS: Over a 3-year period, skin dose data were recorded for 800 instances of 21 interventional radiology procedures. Wide variation in PSD was observed for different instances of the same procedure. Some instances of each procedure we studied resulted in a PSD greater than 2 Gy, except for nephrostomy, pulmonary angiography, and inferior vena cava filter placement. Some instances of transjugular intrahepatic portosystemic shunt (TIPS) creation, renal/visceral angioplasty, and angiographic diagnosis and therapy of gastrointestinal hemorrhage produced PSDs greater than 3 Gy. Some instances of hepatic chemoembolization, other tumor embolization, and neuroembolization procedures in the head and spine produced PSDs greater than 5 Gy. In a subset of 709 instances of higher-dose procedures, there was good overall correlation between PSD and cumulative dose (r = 0.86; P <.000001) and between PSD and dose-area-product (r = 0.85, P <.000001), but there was wide variation in these relationships for individual instances. CONCLUSIONS: There are substantial variations in PSD among instances of the same procedure and among different procedure types. Most of the procedures observed may produce a PSD sufficient to cause deterministic effects in skin. It is suggested that dose data be recorded routinely for TIPS creation, angioplasty in the abdomen or pelvis, all embolization procedures, and especially for head and spine embolization procedures. Measurement or estimation of PSD is the best method for determining the likelihood of radiation-induced skin effects. Skin dose mapping is preferable to a single-point measurement of PSD.     

用胶片法对心脏介入程序中患者峰值皮肤剂量测量研究

目的 采用胶片法对进行心血管介入手术中患者所受峰值皮肤剂量（PSD）进行测量研究,包括冠状动脉血管造影术（CA）和经皮穿刺腔内冠状动脉成形术（PTCA）。方法 选用Gafchromic XR-RV3胶片在两家医院进行患者峰值皮肤剂量的测量。手术时将胶片放在患者身下的诊视床上。记录手术中监视器上显示的kV、mA、透视时间、剂量面积乘积（DAP）、参考点累积剂量等相关信息。采用Epson V750平板扫描仪对胶片进行分析扫描及分析,选用FilmQA软件分别测量图像的红、绿、蓝三色通道的像素值,使用红通道数据计算患者的 PSD。对PSD与设备显示参数进行相关分析,对相关的变量进行多元线性回归分析。结果 共测量CA手术26例,CA+PTCA手术19例。CA手术中,透视时间最高为17.62 min,累积剂量和DAP最大分别为1 498.50 mGy和109.68 Gy ·cm²,PSD最大为361.20 mGy。CA+PTCA手术中,曝光时间最长为64.48 min,累积剂量和DAP最大分别为6 976.20 mGy和5 336.00 Gy ·cm²,17例患者的PSD在1 Gy以内,1例患者PSD在1~2 Gy之间,1例患者PSD超出了发生皮肤损伤2 Gy的阈值,达到了2 195.70 mGy。CA程序中,患者PSD与DAP相关（R²=0.815,P<0.05）,CA+PTCA程序中,患者PSD与累积剂量相关（R²=0.916,P<0.05）。结论 心脏介入放射学程序中部分患者的PSD会超出ICRP建议的发生皮肤确定性效应的2 Gy阈值。DSA设备上显示的剂量相关的参数,只能粗略估算患者PSD的大小。使用XR-RV3胶片精确测量介入手术中患者的峰值皮肤剂量是一种非常快捷、有效的方法。     

神经介入手术中患者峰值皮肤剂量水平研究

目的 获得神经介入手术中患者峰值皮肤剂量数据（PSD）,评估患者确定性效应发生风险。方法 使用Gafchromic XR RV3胶片采集北京市某三级甲等医院神经介入手术患者的峰值皮肤剂量,主要研究血管栓塞术、血管成形术、血管造影术等3种常见的神经介入手术。使用Epson Expression 10000XL扫描仪扫描胶片,利用ImageJ和Film QA Pro^TM 2014软件测量和分析胶片。结果 共采集49例神经介入手术患者的峰值皮肤剂量数据,包括血管栓塞术23例、血管成形术14例、血管造影术12例。PSD ≥ 2 Gy患者20例,其中血管栓塞术15例,血管成形术5例。血管造影术患者的PSD均<2 Gy。部分神经介入手术患者的峰值皮肤剂量超过国际放射防护委员会（ICRP）第118号报告中的确定性效应剂量阈值。结论 神经介入手术存在发生确定性效应的风险,建议针对风险较高的患者进行随访观察,及时了解其辐射损伤情况和后续诊治。     

Kodak EDR2 film for patient skin dose assessment in cardiac catheterization procedures

Patient skin doses were measured using Kodak EDR2 film for 20 coronary angiography (CA) and 32 percutaneous transluminal coronary angioplasty (PTCA) procedures. For CA, all skin doses were well below 1 Gy. However, 23% of PTCA patients received skin doses of 1 Gy or more. Dose-area product (DAP) was also recorded and was found to be an inadequate indicator of maximum skin dose. Practical compliance with ICRP recommendations requires a robust method for skin dosimetry that is more accurate than DAP and is applicable over a wider dose range than EDR2 film.     

Entrance skin dose estimates derived from dose-area product measurements in interventional radiological procedures.

Patient skin doses resulting from interventional radiological procedures have the potential to exceed threshold doses for deterministic effects such as erythema and epilation. If the irradiation geometry is known, the entrance skin dose can be estimated from the measured dose-area product. For each of 10 non-coronary interventional procedures, a nominal geometry was identified. From a previous survey of patient dose-area products, the entrance skin doses were estimated under the assumption that all procedures were performed with the nominal geometry specific to it. An analysis of the uncertainties in these doses caused by realistic deviations from the nominal geometry was also performed and it was shown that the estimated entrance skin dose values are at least to within 40%, and generally to within about 30%, of those actually received. For example, the median estimated entrance skin doses for the posteroanterior and lateral projections of cerebral angiography were 100 and 110 mGy. respectively, and for hepatic angiography 425 mGy. The largest entrance skin dose estimate for a single projection was for the angiography component of a CT arterial portography procedure at 670 mGy. Comparisons between entrance skin dose estimates obtained from this study are made with data from other interventional radiology patient dose surveys.     

Radiation dose in neuroradiological procedures

Summary Radiation dose is cumulative in the radiosensitive organs. In neuroradiology the organ of particular interest is the eye. There is an immutable physical relationship between spatial resolution, signal-to-noise ratio (i.e., density discrimination), and dose:Optimal imaging conditions require a compromise between these three factors. The factors concerned in the effective utilisation of dose are discussed and the various compromises considered. Radiation dose measurements are given for a wide variety of neuroradiological procedures, including CT employing the EMI CT1010 and CT5005.     

Venous malformations: MR imaging features that predict skin burns after percutaneous alcohol embolization procedures

OBJECTIVE: To examine the value of magnetic resonance (MR) imaging for predicting the occurrence of skin burns in patients with venous malformations who undergo percutaneous alcohol embolization was the objective of the study. MATERIALS AND METHODS: Pre-procedural MR imaging at 1.5 T from 40 patients with venous malformations who had undergone percutaneous alcohol embolization was retrospectively reviewed by two observers for these features: anatomic location, definition (well-defined or ill-defined), and the presence of skin, subcutaneous tissue, muscle, tendon, bone, joint, and deep venous system involvement. One observer recorded the length of skin involvement and volume of the malformation. Univariate and multivariate analysis tests were used to determine whether an association between the occurrence of skin burns and MR imaging features existed. RESULTS: The anatomic locations of the venous malformations were the lower extremity (20 out of 40), upper extremity (11 out of 40), trunk (four out of 40), head/neck (three out of 40) and pelvis (two out of 40). Of the 40 subjects, 15% (six out of 40) experienced skin burns. There was a significant association between the absence of muscle involvement (p = 0.0198) as well as the length of skin involvement (p = 0.027), with the occurrence of skin burns. Malformation size and all other features were not significantly associated with skin burns. CONCLUSION: Skin burns in patients with venous malformations treated with alcohol embolization are associated with the length of skin involvement and with the absence of deeper tissue involvement, as depicted on MR imaging.     

Suitability of resin-coated photographic paper for skin dose measurement during fluoroscopically-guided X-ray procedures

The need for mapping skin doses during fluoroscopically-guided X-ray procedures has been described by a number of institutions and experts. Different large photographic or X-ray films placed on the patient's skin have been found to be useful for recording doses up to 1.0-2.0 Gy - depending on the film - and up to 15 Gy using radiochromic films. Though the upper limit of the film sensitivity is seldom exceeded during interventional procedures, the main disadvantage of the X-ray films is still the excessive sensitivity for long, high dose procedures. Radiochromic films show poor definition for doses below 0.5 Gy and are expensive. The goal of the present paper is to analyse the possibilities of using common resin-coated photographic paper for this purpose. Sensitometric curves obtained with different paper types processed in conventional X-ray film automatic processors demonstrate that some of them can be used with better results than X-ray films at a very low cost. Doses from about 10 mGy to near 3.0 Gy can be measured with good accuracy using a variety of glossy photographic papers.     

Measurement of radiation dose in cerebral CT perfusion study

PURPOSE: To evaluate radiation dose in cerebral perfusion studies with a multi-detector row CT (MDCT) scanner on various voltage and current settings by using a human head phantom. MATERIALS AND METHODS: Following the CT perfusion study protocol, continuous cine scans (1 sec/rotation x60 sec) consisting of four 5-mm-thick contiguous slices were performed three times at variable tube voltages of 80 kV, 100 kV, 120 kV, and 140 kV with the same tube current setting of 200 mA and on variable current settings of 50 mA, 100 mA, 150 mA, and 200 mA with the same tube voltage of 80 kV. Radiation doses were measured using a total of 41 theroluminescent dosimeters (TLDs) placed in the human head phantom. Thirty-six TLDs were inside and three were on the surface of the slice of the X-ray beam center, and two were placed on the surface 3 cm caudal assuming the lens position. RESULTS: Average radiation doses of surface, inside, and lens increased in proportion to the increases of tube voltage and tube current. The lowest inside dose was 87.6+/-15.3 mGy, and the lowest surface dose was 162.5+/-6.7 mGy at settings of 80 kV and 50 mA. The highest inside dose was 1,591.5+/-179.7 mGy, and the highest surface dose was 2,264.6+/-123.7 mGy at 140 kV-200 mA. At 80 kV-50 mA, the average radiation dose of lens was the lowest at 5.5+/-0.0 mGy. At 140 kV-200 mA the radiation dose of lens was the highest at 127.2+/-0.6 mGy. CONCLUSION: In cerebral CT perfusion study, radiation dose can vary considerably. Awareness of the patient's radiation dose is recommended.